Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 12”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Not applicableUnknownNCT03288363
What this trial is testing

Transcranial Direct Current Stimulation and Early Alzheimer's Disease (tDCS-AD)

Who this might be right for
Alzheimer Disease
Benjamin CALVET 80
Testing effectiveness (Phase 2)Ended earlyNCT02249351
What this trial is testing

Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 54
Post-approval studies (Phase 4)Study completedNCT00234637
What this trial is testing

Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment

Who this might be right for
Alzheimer's Disease
Novartis 204
Testing effectiveness (Phase 2)Study completedNCT02249403
What this trial is testing

Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 362
Large-scale testing (Phase 3)Study completedNCT00829374
What this trial is testing

Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil

Who this might be right for
Alzheimer's Disease
Medivation, Inc. 1,003
Testing effectiveness (Phase 2)Study completedNCT02471196
What this trial is testing

Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Orion Corporation, Orion Pharma 308
Not applicableUnknownNCT00703430
What this trial is testing

Memantine on Aggression and Agitation of Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Peking University 50
Large-scale testing (Phase 3)Looking for participantsNCT06534723
What this trial is testing

Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)

Who this might be right for
Alzheimer's Dementia
Sichuan Jishengtang Pharmaceutical Co., Ltd. 570
Large-scale testing (Phase 3)Ended earlyNCT02586909
What this trial is testing

12-Month Open-Label Extension Study of Intepirdine (RVT-101) in Subjects With Alzheimer's Disease: MINDSET Extension

Who this might be right for
Alzheimer's Disease
Axovant Sciences Ltd. 1,099
Very early researchStudy completedNCT01024660
What this trial is testing

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

Who this might be right for
Alzheimer's Disease
AstraZeneca 155
Post-approval studies (Phase 4)Study completedNCT01047579
What this trial is testing

A 12 Week, Multicenter, Open Label Evaluation of Caregiver Preference, Safety and Tolerability of Exelon® Patch (Rivastigmine Transdermal) in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 51
Not applicableStudy completedNCT02860338
What this trial is testing

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

Who this might be right for
Mild Cognitive ImpairmentDementiaHypoxia+14 more
Clionsky Neuro Systems Inc. 900
Not applicableUnknownNCT03352739
What this trial is testing

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 30
Large-scale testing (Phase 3)Ended earlyNCT05169008
What this trial is testing

Evaluate the Safety and Immunogenicity of Ad5-nCoV and Ad5-nCoV-IH in CoronaVac Immunized Children and Adolescents

Who this might be right for
COVID-19
CanSino Biologics Inc. 91
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Not applicableStudy completedNCT06898424
What this trial is testing

Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression

Who this might be right for
Alzheimer Type DementiaAlzheimer's Disease (AD)
Prof. Lutfu Hanoglu, MD 60
Testing effectiveness (Phase 2)Study completedNCT00501111
What this trial is testing

Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
AstraZeneca 659
Large-scale testing (Phase 3)Study completedNCT03594123
What this trial is testing

A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer's Disease
Otsuka Pharmaceutical Development & Commercialization, Inc. 259
Testing effectiveness (Phase 2)Looking for participantsNCT06362707
What this trial is testing

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Who this might be right for
Cognitive Decline, MildAlzheimer Disease
Helse Stavanger HF 200
Load More Results